RESEARCH

Parmantier & Cie. Research

Since taking over Frankfurt Main Research AG, Parmantier & Cie. has further expanded its expertise in equity research. Under the name Parmantier & Cie. Research We offer in-depth analyses and reports on listed companies, particularly in the German SME sector. Our research department provides independent and detailed insights to provide institutional investors with a solid basis for their investment decisions.

In our research section, you can find all the latest analyses and coverage reports:

Indus Holding AG

Update march 2026

Published on

30 March 2026

Clinuvel Pharmaceuticals Ltd.

Update März 2026

Published on

25 March 2026

Indus Holding AG

Update: 2025 as expected — free cash flow significantly stronger

Published on

25 February 2026

Clinuvel Pharmaceuticals Ltd

Walk&Talk

Published on

23 February 2026

Lodgyslife AG

Walk & Talk

Published on

15 December 2025

HausVorteil AG

Outdated - Initial Study "Equity Release"

Published on

01 December 2025

Lodgyslife AG

Update

Published on

21 November 2025

INDUS Holding AG

Q3 Update

Published on

17 November 2025

CLINUVEL Pharmaceuticals Ltd

Update: growth, tariff advantage, Nasdaq uplisting

Published on

30 September 2025

INDUS Holding AG

Q2 Update

Published on

15 August 2025

DWK Deutsche Wasserkraft AG

Initial study 'Renewable Energy'

Published on

08 July 2025

CLINUVEL Pharmaceuticals Ltd.

CLINUVEL Update: CEO-Comeback & US-Offensive

Published on

23 June 2025

INDUS Holding AG

UPDATE: Robust despite headwinds

Published on

19 May 2025

INDUS Holding AG

UPDATE: Vision for growth up to 2030

Published on

28 March 2025

CLINUVEL Pharmaceuticals Ltd.

UPDATE: Temporary CEO change

Published on

24 March 2025

CLINUVEL Pharmaceuticals Ltd.

Half-Year Results 'PHARMA/BIOTECH'

Published on

07 March 2025

INDUS Holding AG

2024 UPDATE 'INDUSTRY'

Published on

25 February 2025

CLINUVEL Pharmaceuticals Ltd.

UPDATE STRATEGY 'PHARMA/BIOTECH'

Published on

10 February 2025

INDUS Holding AG

Q3 UPDATE 'INDUSTRY‘

Published on

18 November 2024

Lodgyslife AG

INITIAL STUDY 'LEISURE'

Published on

01 October 2024

CLINUVEL Pharmaceuticals Ltd.

INITIAL STUDY PHARMA/BIOTECH

Published on

09 September 2024

INDUS Holding AG

INITIAL STUDY 'INDUSTRY

Published on

28 August 2024

ANALYSTS

Daniel Großjohann

dg@parmantiercie.com

Thomas Schiessle

ts@parmantiercie.com

Benedikt Krämer

kraemer@parmantiercie.com

Burkay Inci

inci@parmantiercie.com

CONTACT & CORRESPONDENCE

Let’s Talk.

Trennwelle weiß

Trennwelle weiß

Thank you for your interest in Parmantier & Cie.! We are looking forward to the exchange. Feel free to contact us without obligation — we will get back to you.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Parmantier & Cie. GmbH
Hungener Str. 6
60389 Frankfurt am Main

T +49 69 59673008

Geschäftsführer René Parmantier
HRB 113833
Amtsgericht Frankfurt a. M.
Steuer-Nr. 047 241 06849
USt-IdNr. DE 327975773